Although we did not evaluate which stages were related to the adequate and highest PD-L1 expressing yields in adenocarcinoma cases, 86.9% (166) of the 191 identified adenocarcinoma cases were identified at advanced stages (III and IV). The gene discussed is CD274; the disease is adenocarcinoma.